<DOC>
	<DOCNO>NCT00517725</DOCNO>
	<brief_summary>The investigator test hypothesis different beta-blockers different influence chemoreceptor response lung diffusion capacity . Both could influence exercise capacity normoxic well hypoxic condition .</brief_summary>
	<brief_title>Nebivolol Versus Bisoprolol Versus Carvedilol Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Chronic heart failure patient stable clinical condition No comorbidity NYHA class IV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>exercise</keyword>
	<keyword>lung diffusion</keyword>
	<keyword>hypoxia</keyword>
	<keyword>chemoreceptor</keyword>
	<keyword>beta-blockers</keyword>
	<keyword>heart failure</keyword>
</DOC>